1-2 of 2
Shengli (Charles) Cai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lbl-043, a Novel LILRB4xCD3 T Cell Engager, for the Treatment of Relapsed/Refractory Multiple Myeloma

Yujia Dang, Xiao Huang, Yurong Qin, Xiaoya Liu, Min Chen, Duqing Jiang, Mi Ye, Guojin Wu, Jianming Sun, Jing Guan, Jordan Zhu, Shengli (Charles) Cai, Shoupeng Lai, Xiaoqiang Kang, Hong Ling
Journal: Blood
Blood (2024) 144 (Supplement 1): 5827.
https://doi.org/10.1182/blood-2024-209139
Published: 2024
Journal Articles

An Uniquely Designed Asymmetric Bispecific Antibody Against GPRC5D and CD3 (LBL-034) in Patients with Relapsed/Refractory Multiple Myeloma: A Phase I/II, First in Human, Open-Label, Multicenter, Dose Escalation/Expansion Study

Ling Qin, Yuping Zhong, Dongping Huang, Haitang Xie, Xin Du, Aijun Liao, Hongli Zhang, Shengli (Charles) Cai, Jin Lu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4736.
https://doi.org/10.1182/blood-2024-202871
Published: 2024